DE602006004197D1 - Querverweise von tetrahydrothiopyrano-pyrazol-cannabinoidmodulatoren zu verwandten anmeldungen - Google Patents

Querverweise von tetrahydrothiopyrano-pyrazol-cannabinoidmodulatoren zu verwandten anmeldungen

Info

Publication number: DE602006004197D1
Authority: DE; Germany
Prior art keywords: tetrahydrothiopyrano; pyrazol; related applications; cross references; cannabinoid modulators
Prior art date: 2005-03-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

DE602006004197T

Other languages

English (en)

Inventor

Fina Liotta

Huajun Lu

Mingde Xia

Michael P Wachter

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Pharmaceutica NV

Original Assignee

Janssen Pharmaceutica NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-31

Filing date

2006-03-16

Publication date

2009-01-22

2006-03-16 Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV

2009-01-22 Publication of DE602006004197D1 publication Critical patent/DE602006004197D1/de

Status Active legal-status Critical Current

2026-03-17 Anticipated expiration legal-status Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Addiction (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DE602006004197T 2005-03-31 2006-03-16 Querverweise von tetrahydrothiopyrano-pyrazol-cannabinoidmodulatoren zu verwandten anmeldungen Active DE602006004197D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US66689805P	2005-03-31	2005-03-31
PCT/US2006/009424 WO2006107561A1 (en)	2005-03-31	2006-03-16	Tetrahydrothiopyrano pyrazole cannabinoid modulators

Publications (1)

Publication Number	Publication Date
DE602006004197D1 true DE602006004197D1 (de)	2009-01-22

Family

ID=36587178

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602006004197T Active DE602006004197D1 (de)	2005-03-31	2006-03-16	Querverweise von tetrahydrothiopyrano-pyrazol-cannabinoidmodulatoren zu verwandten anmeldungen

Country Status (18)

Country	Link
US (2)	US20060223798A1 (de)
EP (1)	EP1863479B1 (de)
JP (1)	JP5127697B2 (de)
KR (1)	KR20080004559A (de)
CN (1)	CN101189007A (de)
AT (1)	ATE416768T1 (de)
AU (1)	AU2006232945B2 (de)
BR (1)	BRPI0609790A2 (de)
CA (1)	CA2603104A1 (de)
CO (1)	CO6321135A2 (de)
CR (1)	CR9479A (de)
DE (1)	DE602006004197D1 (de)
EA (1)	EA200702130A1 (de)
IL (1)	IL186430A0 (de)
MX (1)	MX2007012233A (de)
NO (1)	NO20075463L (de)
WO (1)	WO2006107561A1 (de)
ZA (1)	ZA200709342B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101863903B (zh) *	2010-06-08	2014-03-12	沈阳药科大学	1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2800375B1 (fr) *	1999-11-03	2004-07-23	Sanofi Synthelabo	Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
CA2399791A1 (en) *	2000-02-11	2001-08-16	Bristol-Myers Squibb Company	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
CA2464333C (en) *	2001-10-26	2011-07-26	University Of Connecticut	Heteroindanes: a new class of potent cannabimimetic ligands
US20040214856A1 (en) *	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) *	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof

2006
- 2006-03-16 EA EA200702130A patent/EA200702130A1/ru unknown
- 2006-03-16 AT AT06738484T patent/ATE416768T1/de not_active IP Right Cessation
- 2006-03-16 BR BRPI0609790-1A patent/BRPI0609790A2/pt not_active IP Right Cessation
- 2006-03-16 DE DE602006004197T patent/DE602006004197D1/de active Active
- 2006-03-16 KR KR1020077025259A patent/KR20080004559A/ko not_active Withdrawn
- 2006-03-16 CN CNA2006800192594A patent/CN101189007A/zh active Pending
- 2006-03-16 WO PCT/US2006/009424 patent/WO2006107561A1/en not_active Ceased
- 2006-03-16 EP EP06738484A patent/EP1863479B1/de active Active
- 2006-03-16 MX MX2007012233A patent/MX2007012233A/es active IP Right Grant
- 2006-03-16 AU AU2006232945A patent/AU2006232945B2/en not_active Ceased
- 2006-03-16 CA CA002603104A patent/CA2603104A1/en not_active Abandoned
- 2006-03-16 JP JP2008504108A patent/JP5127697B2/ja not_active Expired - Fee Related
- 2006-03-16 US US11/376,844 patent/US20060223798A1/en not_active Abandoned
2007
- 2007-10-07 IL IL186430A patent/IL186430A0/en unknown
- 2007-10-17 CO CO07109275A patent/CO6321135A2/es not_active Application Discontinuation
- 2007-10-29 NO NO20075463A patent/NO20075463L/no not_active Application Discontinuation
- 2007-10-29 CR CR9479A patent/CR9479A/es not_active Application Discontinuation
- 2007-10-30 ZA ZA200709342A patent/ZA200709342B/xx unknown
- 2007-12-07 US US11/952,375 patent/US7524964B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20060223798A1 (en)	2006-10-05
JP5127697B2 (ja)	2013-01-23
US20080085899A1 (en)	2008-04-10
WO2006107561A1 (en)	2006-10-12
CR9479A (es)	2008-09-09
AU2006232945B2 (en)	2012-02-23
EP1863479B1 (de)	2008-12-10
KR20080004559A (ko)	2008-01-09
CO6321135A2 (es)	2011-09-20
CA2603104A1 (en)	2006-10-12
NO20075463L (no)	2007-12-21
ATE416768T1 (de)	2008-12-15
BRPI0609790A2 (pt)	2010-04-27
ZA200709342B (en)	2009-09-30
JP2008535829A (ja)	2008-09-04
US7524964B2 (en)	2009-04-28
IL186430A0 (en)	2008-01-20
CN101189007A (zh)	2008-05-28
EA200702130A1 (ru)	2008-04-28
EP1863479A1 (de)	2007-12-12
MX2007012233A (es)	2008-03-18
AU2006232945A1 (en)	2006-10-12

Publication	Publication Date	Title
TW200602324A (en)	2006-01-16	Tetrahydro-indazole cannabinoid modulators cross reference to related applications
IL190348A0 (en)	2009-09-22	Hexahydro cyclooctyl pyrazole cannabinoid modulators
ATE484505T1 (de)	2010-10-15	5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten
NO20082505L (no)	2008-08-12	Substtuert 5-heteroaryl-1-fenyl-pyrazol-cannabinoid-modulatorer
DE602005026037D1 (de)	2011-03-03	Tetrahydro pyridinyl pyrazole cannabinoid modulatoren
MX2010001714A (es)	2010-03-10	Moduladores de canabinoides 5-vinilfenil-1-fenil-pirazol sustituidos.
BRPI0409580A (pt)	2006-04-18	compostos de quinazolina
TW200733961A (en)	2007-09-16	Diaryl urea for treating pulmonary hypertension
EA200600590A1 (ru)	2006-08-25	Фармацевтические композиции модафинила с модифицированным высвобождением
UA98487C2 (en)	2012-05-25	Hexahydro-cycloheptapyrazole cannabinoid modulators
ZA200803532B (en)	2009-09-30	Hexahydro-cycloheptapyrazole cannabinoid modulators
ATE416768T1 (de)	2008-12-15	Querverweise von tetrahydrothiopyrano-pyrazol- cannabinoidmodulatoren zu verwandten anmeldungen
ATE538122T1 (de)	2012-01-15	Acetamid- und carboxamid-derivate von azaadamantan sowie verfahren zu ihrer verwendung
MX2009010159A (es)	2009-10-12	Moduladores de cannabinoides hexahidro-ciclooctil pirazol.
DK1377294T3 (da)	2006-07-24	Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination
UA91385C2 (ru)	2010-07-26	Диарилмочевина для лечения легочной гипертензии
WO2005041875A3 (en)	2005-11-24	Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications

Legal Events

Date	Code	Title	Description
2009-12-31	8364	No opposition during term of opposition